Choose your country to see the products for your location
We’ve recently updated the digitalMLPA General Protocol to reflect a new recommendation for read depth - read more about this change.
We were delighted to attend the 2025 edition of the European Human Genetics Conference in Milan, Italy - read further for our re-cap.
Introducing NXtec—the new product line name for all currently available digitalMLPA assays. This change helps us clearly distinguish our current assays from future variants that may require different protocols or reagents.
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! The first batch of flagship products are already available on the market under the new IVDR, well in advance of the transition period deadline.
We were delighted to attend the 2025 edition of the European Human Genetics Conference in Milan, Italy - read further for our re-cap.
Testing for TERT promoter mutations in certain skin lesions can provide valuable insights - find out which MLPA probemixes can be used to test for these variants.
Join our mailing list to receive the latest information about our products, technologies and website.